Table 2.
N | Overall survival 1 year, 3 years |
p-Value | |
---|---|---|---|
No. of nodes taken | 0.592 | ||
1–15 | 149 | 80%, 36% | |
16–20 | 155 | 70%, 40% | |
21–25 | 125 | 70%, 31% | |
>25 | 114 | 69%, 34% | |
No. of positive nodes | <0.001a | ||
0 | 148 | 84%, 62% | |
1–2 | 132 | 72%, 35% | |
3–5 | 146 | 65%, 26% | |
>5 | 118 | 57%, 14% | |
LN ratio | <0.001a | ||
0.00 | 147 | 85%, 63% | |
0.01–0.15 | 142 | 74%, 38% | |
0.16–0.25 | 114 | 59%, 18% | |
>0.25 | 140 | 60%, 18% |
Survival is reported as Kaplan–Meier estimates at 1 and 3 years, and p-values are from Log-Rank tests based on all available follow-up.
Significant at p < 0.05.